Analytical Data
-
Gene name
NXPH4
- Application
-
Alternative Names
NPH4
-
Species
Mouse
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
G3X9N5
-
Expression Region
His116~Gly304
-
Molecular Weight
24&22kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
NXPH4, or Neurexophilin 4, is a protein that plays a significant role in the nervous system by modulating neurotransmitter release and synaptic function. Understanding NXPH4 is vital because it is implicated in various neurobiological processes, including neural development, synaptic plasticity, and potentially in the pathology of neurodegenerative diseases. Recent studies have highlighted its association with synaptic transmission and interactions with neuronal receptors, suggesting that it could be a key player in maintaining synaptic integrity and function. Given the increasing prevalence of neurological disorders globally, the exploration of NXPH4 and its functional mechanisms has garnered attention in the scientific community. Researchers are focusing on the recombinant expression of NXPH4 to investigate its structure-function relationship and to explore its potential therapeutic applications. By producing NXPH4 as a recombinant protein, scientists can study its interactions at the cellular level, enabling a deeper understanding of its role in synaptic dynamics and its potential as a target for drug development aimed at treating synaptic dysfunctions in various neurological disorders. This research is crucial for developing strategies to mitigate the impact of diseases such as Alzheimer's and other neurodegenerative conditions, making NXPH4 a significant focus of contemporary neuroscience research.
